episode 70

Overcoming the data challenges of AI-driven drug discovery

Data Science Leaders | 36:49 | March 28, 2024

Get new episodes 
in your inbox

Return to podcast home

A human being consists of billions of cells, each with the same genetic code but interacting in a myriad ways that can eventually translate into disease. Understanding and treating that disease is, in essence, a data problem. But how do you unlock that data and how do you change an organization to systematically use that data to improve decision-making and accelerate drug discovery?

In this episode, we speak with Volodimir Olexiouk, Director of Scientific Engagement and Data Science Team Lead at BioLizard, about best practices for overcoming the data challenges for AI-driven drug discovery and combining scientific expertise with data science for augmented intelligence in the life sciences.

Join us as we discuss:

  • The challenges in discerning correlation from causation and integrating domain expertise
  • How bridging expertise gaps and merging data silos in pharmaceutical companies radically improves drug-discovery processes
  • The promise AI holds for swifter and more effective responses to future pandemics

Popular episodes

James Cham

Partner, Bloomberg Beta

EPISODE 71April 11, 2024

Unlocking the disruptive potential of generative AI: a VC perspective

Listen Now | 28:49

Rahul Todkar

Head of Data and AI, Tripadvisor

EPISODE 69March 14, 2024

AI Will Plan Your Next Vacation: GenAI at Tripadvisor

Listen Now | 30:11
Data Science Leaders: David Von Dollen

David Von Dollen

Head of AI

EPISODE 68February 29, 2024

From the Archive: A Hybrid Approach to Accelerating the Model Lifecycle

Listen Now | 23:34

See why Fortune 100 data science leaders choose Domino